Pregnenolone for Cognitive and Negative Symptoms in Schizophrenia

• Status: Completed
• Trial end date: 2015-12-01

Summary

This study will investigate adjunctive pregnenolone for patients with schizophrenia and schizoaffective disorder.

• Phase: Phase 2

Details

• Lead Sponsor: VA Office of Research and Development